Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
01/18/2024 | RONALD BLUE TRUST, INC. | 4,000 | $1,000 | 0.00% | 0.33% |
02/12/2024 | JPMORGAN CHASE & CO | 0 | $0 | -100.00% | 0.00% |
02/06/2024 | LINCOLN NATIONAL CORP | 0 | $0 | -100.00% | 0.00% |
02/09/2024 | WELLS FARGO & COMPANY/MN | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | NORTHERN TRUST CORP | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | STATE STREET CORP | 0 | $0 | -100.00% | 0.00% |
03/11/2024 | VANGUARD GROUP INC | 0 | $0 | -100.00% | 0.00% |
01/22/2024 | PERKINS CAPITAL MANAGEMENT INC | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | MORGAN STANLEY | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | GROUP ONE TRADING, L.P. | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | CREDIT AGRICOLE S A | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | BLACKROCK INC. | 0 | $0 | -100.00% | 0.00% |
02/14/2024 | LPL FINANCIAL LLC | 0 | $0 | -100.00% | 0.00% |
02/01/2024 | SIGNATUREFD, LLC | 0 | $0 | -100.00% | 0.00% |
02/12/2024 | HIGHTOWER ADVISORS, LLC | 0 | $0 | -100.00% | 0.00% |
02/09/2024 | HRT FINANCIAL LP | 0 | $0 | -100.00% | 0.00% |
01/18/2024 | CUTLER GROUP LLC / CA | 0 | $0 | -100.00% | 0.00% |
02/09/2024 | UBS GROUP AG | 0 | $0 | -100.00% | 0.00% |
01/30/2024 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0 | $0 | -100.00% | 0.00% |
02/12/2024 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0 | $0 | -100.00% | 0.00% |
02/13/2024 | QUBE RESEARCH & TECHNOLOGIES LTD | 0 | $0 | -100.00% | 0.00% |
01/18/2024 | GLOBAL RETIREMENT PARTNERS, LLC | 0 | $0 | -100.00% | 0.00% |
01/17/2024 | KOZAK & ASSOCIATES, INC. | 0 | $0 | -100.00% | 0.00% |
02/08/2024 | APEXIUM FINANCIAL, LP | 0 | $0 | -100.00% | 0.00% |
01/16/2024 | STRATEGIC WEALTH INVESTMENT GROUP, LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 7 institutional investors and hedge funds held shares of Vivos Therapeutics, Inc.. The most heavily invested institutionals were:
Ronald Blue Trust, Inc.: 0
Strategic Wealth Investment Group, LLC: 0
JPMORGAN CHASE & CO: 0
STATE STREET CORP: 0
NORTHERN TRUST CORP: 0
GEODE CAPITAL MANAGEMENT, LLC: 0
A. 0.33% of Vivos Therapeutics, Inc. stock is owned by institutional investors.